(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...